Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Fresubin Support Drink for Enteral Nutrition Support in Perioperative Patients With Gastrointestinal Cancer: A Prospective, Randomized, Open-Label, Active-Controlled Multi-Center Clinical Trial

NCT05606848 is registered in ClinicalTrials.gov with Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd as lead sponsor.

NCT NCT05606848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05606848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Fresubin Support Drink for Enteral Nutrition Support in Perioperative Patients With Gastrointestinal Cancer: A Prospective, Randomized, Open-Label, Active-Controlled Multi-Center Clinical Trial
Lead sponsor
Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2022
Completion date
March 31, 2025
Enrollment
350 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal cancer